Jeff Burgess, MD, MPH, professor in the Mel and Enid Zuckerman College of Public Health, discusses a recent announcement from the World Health Organization officially declaring firefighting a cancer-causing profession.

Since the COVID-19 vaccines first began rolling out last winter, recipients have noticed unexpected menstrual bleeding after getting the shots. A recent survey of tens of thousands of adults confirms that this experience is relatively common.

Two bioinformaticists are dedicated to improving research by applying computer science, mathematics and statistics to analyze biological data.

Katrina Zearley, a student in the R. Ken Coit College of Pharmacy, discusses why she wrote a children’s book about pharmacy.

A University of Arizona Health Sciences study of COVID-19 vaccine effectiveness and immunity among frontline workers, families and children has received $22 million from the U.S. Centers for Disease Control and Prevention to continue the research for another year.

COVID vaccine makers are developing new boosters for a fall campaign. But some experts question the FDA's decision to tell companies to make shots against the BA.4/5 subvariants.

CDC funding will allow research on COVID-19 immunity and vaccine effectiveness to continue as new variants emerge.

The new BA-5 variant of the coronavirus is now the dominant strain in Arizona, where it is responsible for slightly less than 60% of new cases.

A commonly prescribed cancer and arthritis drug sometimes used as an oral abortifacient is facing prescription roadblocks in wake of the Supreme Court's overturning of Roe v Wade.